Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.
About This Bill
Committee
Latest Action · February 25, 2026
Referred to the House Committee on Energy and Commerce.
H.Res. 1079 is a symbolic resolution that recognizes Charcot-Marie-Tooth disease (CMT), a genetic nerve disorder affecting an estimated 126,000 Americans and 2.6 million people worldwide, and calls for increased federal research funding to combat the disease. The resolution notes that CMT damages peripheral nerves and can impair muscle control, yet federal funding for CMT research actually decreased from 2021 to 2022 despite its significant public health impact. The resolution urges the National Institute of Neurological Disorders and Stroke at the National Institutes of Health to provide robust funding for CMT research and to continue investing in efforts to develop treatments and cures for this and other rare diseases. As a House resolution, this measure does not authorize or appropriate specific funding amounts; rather, it expresses the sense of Congress that CMT deserves greater research priority and investment.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.